Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins | Oncogene
PDF] Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells. | Semantic Scholar
Chemical structures of ABT-737 (left) and ABT-263 (right ). | Download Scientific Diagram
ABT-737 - Wikipedia
ABT-737 and Roscovitine induces apoptosis in a synergistic fashion in mast cells carrying the D816V KIT mutation
ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]
Rapid Detection of an ABT-737-Sensitive Primed for Death State in Cells Using Microplate-Based Respirometry | PLOS ONE
Combined treatment with ABT-737 and VX-680 induces apoptosis in Bcl-2- and c-FLIP-overexpressing breast carcinoma cells
Cancers | Free Full-Text | The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death
ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL | Journal of Experimental & Clinical Cancer Research | Full Text
ABT-737 | Bcl-2 Family Inhibitor/BH3 Mimetic | MedChemExpress
Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B | Cell Death & Disease
Mechanisms of potentiation of ABT-737 lethality by strategies targeting... | Download Scientific Diagram
ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells [PeerJ]
PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors
Frontiers | BH3 Mimetics for the Treatment of Prostate Cancer
ABT-737 | ≥99%(HPLC) | Selleck | Bcl-2 阻害剤
Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B – topic of research paper in Biological sciences. Download scholarly article
ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin–DNA adducts - ScienceDirect
PDF] Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. | Semantic Scholar
ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells | Leukemia
Navitoclax - Wikipedia
Chemical structure and mode of action of the BH3 mimetic ABT-737 in... | Download Scientific Diagram
Combined treatment with ABT-737 and VX-680 induces apoptosis in Bcl-2- and c-FLIP-overexpressing breast carcinoma cells